October 28: The Week in Cancer News
Clinical trial finds select breast cancer patients can forgo surgery, and more from the week in cancer news.
Progress Against Cancer
Clinical trial finds select breast cancer patients can forgo surgery, and more from the week in cancer news.
The FDA granted accelerated approval to a targeted immunotherapy for patients with relapsed or refractory multiple myeloma. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to teclistamab-cqyv (Tecvayli), a type of...
As more cancer patients take an interest in the science of their care, it’s vital to establish good relationships with doctors
The FDA approved the combination of two checkpoint inhibitors for certain patients with hepatocellular carcinoma. The U.S. Food and Drug Administration (FDA) has approved tremelimumab (Imjudo) in combination with durvalumab (Imfinzi) for adult patients...
Chemical hair straightening is associated with higher uterine cancer risk, and more from the week in cancer news.
New findings may help physicians monitor for adverse reactions to immunotherapy and allow for early intervention. A potentially severe side effect of an immunotherapy used for some types of cancer may be linked to...
AACR patient advocate forum addresses developments in cancer early detection tests.
Colonoscopy study results are misreported, progress is seen in cancer vaccines, and more from the week in cancer news.
Clinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
Transportation barriers increase risk of death for people with cancer, and new rules go into effect to give patients full access to medical records.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More